First Time Loading...

China Resources Medical Holdings Company Ltd
HKEX:1515

Watchlist Manager
China Resources Medical Holdings Company Ltd Logo
China Resources Medical Holdings Company Ltd
HKEX:1515
Watchlist
Price: 4.43 HKD 1.61% Market Closed
Updated: May 14, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

18.5B
+4%
Assets
Growth Rates:
1 Year
+70%
3 Years
+116%
5 Years
+164%
7 Years
+712%
10 Years
+1 462%
12.5B
+51%
Liabilities
Growth Rates:
1 Year
+189%
3 Years
+371%
5 Years
+753%
7 Years
+3 142%
10 Years
+1 295%
6B
-37%
Equity
Growth Rates:
1 Year
-9%
3 Years
+1%
5 Years
+8%
7 Years
+215%
10 Years
+1 990%

Balance Sheet Decomposition
China Resources Medical Holdings Company Ltd

18.5B
Assets
12.5B
Liabilities
18.5B
Assets
12.5B
Liabilities
Current Assets 7.6B
Cash & Short-Term Investments 4.4B
Receivables 2.5B
Other Current Assets 752.8m
Non-Current Assets 10.9B
Long-Term Investments 1.4B
PP&E 5.4B
Intangibles 3.8B
Other Non-Current Assets 222.3m
Current Liabilities 9.6B
Accounts Payable 1.8B
Other Current Liabilities 7.8B
Non-Current Liabilities 3B
Long-Term Debt 1.1B
Other Non-Current Liabilities 1.9B

Balance Sheet
China Resources Medical Holdings Company Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022
Assets
Cash & Cash Equivalents
402
612
822
1 069
877
1 524
2 006
2 701
2 324
3 100
Cash
402
612
822
1 069
877
1 524
2 006
2 701
2 324
3 100
Short-Term Investments
881
461
192
119
715
373
270
270
311
324
Total Receivables
150
170
211
390
455
529
840
930
963
2 575
Accounts Receivables
84
94
138
256
352
508
631
638
794
1 513
Other Receivables
66
77
73
134
104
21
210
293
169
1 062
Inventory
31
34
42
50
39
78
62
142
185
367
Other Current Assets
10
16
27
25
27
29
20
103
141
400
Total Current Assets
1 473
1 293
1 294
1 654
2 114
2 533
3 198
4 147
3 925
6 766
PP&E Net
123
138
145
264
257
259
337
1 046
2 118
5 418
PP&E Gross
123
138
145
264
257
259
337
1 046
2 118
0
Accumulated Depreciation
82
85
109
134
176
218
213
313
447
0
Intangible Assets
317
360
405
2 132
2 112
2 096
2 036
1 346
75
69
Goodwill
0
0
0
1 464
1 464
1 464
1 464
1 472
2 276
3 740
Note Receivable
51
69
109
113
161
162
136
128
59
60
Long-Term Investments
0
0
155
677
666
669
627
748
1 928
1 573
Other Long-Term Assets
159
152
147
144
140
137
76
76
86
192
Other Assets
0
0
0
1 464
1 464
1 464
1 464
1 472
2 276
3 740
Total Assets
2 124
N/A
2 012
-5%
2 255
+12%
6 448
+186%
6 914
+7%
7 319
+6%
7 874
+8%
8 963
+14%
10 468
+17%
17 818
+70%
Liabilities
Accounts Payable
124
172
210
243
257
224
241
564
828
1 734
Accrued Liabilities
18
17
23
59
92
106
106
279
436
0
Short-Term Debt
0
0
0
0
171
491
578
684
1 666
0
Current Portion of Long-Term Debt
200
0
0
0
0
0
5
19
22
1 349
Other Current Liabilities
61
84
157
450
456
456
453
660
493
2 041
Total Current Liabilities
403
273
390
752
977
1 277
1 384
2 207
3 444
5 124
Long-Term Debt
0
0
0
0
0
0
14
47
40
1 053
Deferred Income Tax
0
0
0
319
318
316
318
318
95
71
Minority Interest
99
108
115
119
120
120
236
235
396
1 144
Other Liabilities
5
3
3
20
18
16
18
51
42
915
Total Liabilities
507
N/A
385
-24%
508
+32%
1 210
+138%
1 432
+18%
1 730
+21%
1 970
+14%
2 858
+45%
4 017
+41%
8 308
+107%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
Retained Earnings
75
305
499
1 015
603
191
211
531
960
9 509
Additional Paid In Capital
1 542
1 498
1 383
6 366
6 296
6 181
5 993
5 878
5 785
0
Unrealized Security Profit/Loss
0
0
0
16
16
0
0
0
0
0
Treasury Stock
0
176
141
114
195
385
283
283
280
0
Other Equity
0
0
7
17
1
16
17
21
15
0
Total Equity
1 617
N/A
1 627
+1%
1 748
+7%
5 238
+200%
5 482
+5%
5 589
+2%
5 904
+6%
6 105
+3%
6 451
+6%
9 509
+47%
Total Liabilities & Equity
2 124
N/A
2 012
-5%
2 255
+12%
6 448
+186%
6 914
+7%
7 319
+6%
7 874
+8%
8 963
+14%
10 468
+17%
17 818
+70%
Shares Outstanding
Common Shares Outstanding
834
834
834
1 297
1 297
1 297
1 297
1 297
1 297
1 297

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.